Published on GHDx (https://ghdx.healthdata.org)

Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China

General Info

Geography 
China (CHN)
Time period covered 
January, 2020 - December, 2020
Data type
Scientific literature
Keywords 
COVID-19

Citation

Authors 
Li Z, Guan X, Mao N, Luo H, Qin Y, He N, Zhu Z, Yu J, Li Y, Liu J, An Z, Gao W, Wang X, Sun X, Song T, Yang X, Wu M, Wu X, Yao W, Peng Z, Sun J, Wang L, Guo Q, Xiang N, Liu J, Zhang B, Su X, Rodewald L, Li L, Xu W, Shen H, Feng Z, Gao GF
Journal 
Lancet Reg Health West Pac
Pages 
100094
Publication year 
2021
Suggested citation 
Li Z, Guan X, Mao N, Luo H, Qin Y, He N, Zhu Z, Yu J, Li Y, Liu J, An Z, Gao W, Wang X, Sun X, Song T, Yang X, Wu M, Wu X, Yao W, Peng Z, Sun J, Wang L, Guo Q, Xiang N, Liu J, Zhang B, Su X, Rodewald L, Li L, Xu W, Shen H, Feng Z, Gao GF. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021; 8: 100094.
Source URL:https://ghdx.healthdata.org/record/antibody-seroprevalence-epicenter-wuhan-hubei-and-six-selected-provinces-after-containment#comment-0